CeloNova BioSciences, Inc.

CeloNova BioSciences, Inc. (CeloNova) is a privately held medical device company, which is engaged in developing and manufacturing of safe and effective solutions for complex technological and biomedical problems. The company offers Polyzene-F, a chemical compound with an extensive array of bioscience and industrial applications; Embozene Microspheres, a spherical embolic device for the treatment of neurovascular arteriovenous malformations, uterine fibroids, hepatocellular carcinoma, hypervascularized tumors, and arteriovenous malformations; and CATANIA coronary stent systems for symptomatic ischemic heart disease. The company distributes its products in Austria, Belgium, Luxembourg, Germany, Ireland, Israel, Italy, Poland, Spain, Switzerland, Turkey and the UK. CeloNova is headquartered in Georgia, the US.

In March 2009, the company received the 2009 Frost & Sullivan North American Product Innovation of the Year award in the field of Interventional Cardiology. During December 2008, it received the US FDA market approval for Embozene Color-Advanced microspheres embolization platform.

Street: 
49 Spring Street
City: 
Newnan
Postcode: 
30263
Federal State : 
United States
WebSite: 
www.celonova.com
Fax: 
1-770-5020773

Company Index Score

Current Index Score Historical Index Score
  • CeloNova BioSciences, Inc. currently scores 50 % in the index.
  • CeloNova BioSciences, Inc. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • CeloNova BioSciences, Inc. is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets